CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
National, sub-national, and risk-attributed burden of thyroid cancer in Iran from 1990 to 2019
Authors
M. Abbasi-Kangevari
Z. Abbasi-Kangevari
+93 more
H. Abolhassani
A. Ahmadi
S. Ahmadi
S. Amini
F.I. Amlashi
A.A. Anoushirvani
J. Arabloo
S.S. Athari
S. Azadnajafabad
S. Azadnajafabad
M. Azangou-Khyavy
M. Azangou-Khyavy
S. Besharat
A. Bijani
GBD 2019 Iran Thyroid Cancer Collaborators
A. Daryani
M. Dianatinasab
M. Didehdar
Z. Esfahani
Z. Esfahani
F. Farzadfar
F. Farzadfar
A. Fatehizadeh
S.-H. Ghamari
A. Ghashghaee
P. Goleij
M. Golitaleb
N. Hafezi-Nejad
A. Haj-Mirzaian
S. Hassanipour
A.A. Jafari
H. Jamshidi
H. Jamshidi
A. Kabir
F.P. Kan
M. Keramati
R. Khalilov
M. Khayamzadeh
A.-A. Kolahi
F. Kompani
H.R. Koohestani
B. Larijani
B. Larijani
S. Livani
S. Mahjoub
M.-R. Malekpour
N. Malih
B. Mansouri
S. Mirmoeeni
S.S. Moghaddam
E. Mohammadi
E. Mohammadi
A. Mohammadian-Hafshejani
R. Mohammadpourhodki
A.H. Mokdad
A.H. Mokdad
S. Momtazmanesh
M. Naghavi
M. Naghavi
M. Naghipour
H. Najafi
E.M. Nasab
J. Nazari
S.A. Nejadghaderi
M. Noori
A. Nowroozi
R. Pezzani
S. Rafiei
S. Raoofi
M.-M. Rashidi
M.-M. Rashidi
M.S. Razeghinia
M. Rezaei
N. Rezaei
N. Rezaei
N. Rezaei
N. Rezaei
N. Rezaei
S. Rezaei
S. Rezazadeh-Khadem
S. Saeedi Moghaddam
F. Saeedi
M. Sahebazzamani
A. Sahebkar
S. Shahabi
J. Sharifi-Rad
S. Sheikhbahaei
R. Shirkoohi
P. Shobeiri
S.M. Tavangar
S.M. Tavangar
R. Valizadeh
I. Zare
Publication date
1 January 2022
Publisher
Abstract
An updated exploration of the burden of thyroid cancer across a country is always required for making correct decisions. The objective of this study is to present the thyroid cancer burden and attributed burden to the high Body Mass Index (BMI) in Iran at national and sub-national levels from 1990 to 2019. The data was obtained from the GBD 2019 study estimates. To explain the pattern of changes in incidence from 1990 to 2019, decomposition analysis was conducted. Besides, the attribution of high BMI in the thyroid cancer DALYs and deaths were obtained. The age-standardized incidence rate of thyroid cancer was 1.57 (95 UI: 1.33�1.86) in 1990 and increased 131 (53�191) until 2019. The age-standardized prevalence rate of thyroid cancer was 30.19 (18.75�34.55) in 2019 which increased 164 (77�246) from 11.44 (9.38�13.85) in 1990. In 2019, the death rate, and Disability-adjusted life years of thyroid cancer was 0.49 (0.36�0.53), and 13.16 (8.93�14.62), respectively. These numbers also increased since 1990. The DALYs and deaths attributable to high BMI was 1.91 (0.95�3.11) and 0.07 (0.04�0.11), respectively. The thyroid cancer burden and high BMI attributed burden has increased from 1990 to 2019 in Iran. This study and similar studies� results can be used for accurate resource allocation for efficient management and all potential risks� modification for thyroid cancer with a cost-conscious view. © 2022, The Author(s)
Similar works
Full text
Available Versions
Golestan University of Medical Sciences Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:eprints.goums.ac.ir:11610
Last time updated on 07/10/2022